The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst)
A revised Children's Oncology Group (COG) neuroblastoma risk classification system: Report from the COG biology study ANBL00B1.
 
Meredith Irwin
No Relationships to Disclose
 
Arlene Naranjo
Consulting or Advisory Role - Novartis
 
Susan Lerner Cohn
Stock and Other Ownership Interests - Abbvie; Amgen; Amgen (I); Jazz Pharmaceuticals; Lilly; Merck; Merck (I); Pfizer; Pfizer (I); Resmed (I); Sanofi; Stryker; Stryker (I); United Therapeutics; United Therapeutics (I); Varex Imaging; Varian Medical Systems (I); Vermillion; Vermillion
Research Funding - Merck (Inst); United Therapeutics (Inst)
 
Wendy B London
No Relationships to Disclose
 
Julie M Gastier-Foster
No Relationships to Disclose
 
John M. Maris
Consulting or Advisory Role - Bayer; Lilly
 
Rochelle Bagatell
No Relationships to Disclose
 
Julie R. Park
Honoraria - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Roche
 
Michael D. Hogarty
No Relationships to Disclose